rs72725854: African Ancestry-Specific Prostate Cancer Risk Variant
The rs72725854 variant is a rare genetic marker located in an intergenic region on chromosome 8q24. It is specifically associated with an increased risk of prostate cancer in men of African ancestry.
What each genotype means
Baseline prostate cancer risk
This genotype represents the non-risk allele at the 8q24 locus. Research indicates that individuals with this genotype do not carry the specific risk-associated variants linked to increased prostate cancer susceptibility in populations of African ancestry.
This is the most common genotype observed in populations of African ancestry.
Increased prostate cancer risk
Carrying one copy of the T allele is associated with a significantly increased risk of developing prostate cancer and may be linked to an earlier age at diagnosis. Because this variant influences enhancer activity at the 8q24 locus, individuals with this genotype should discuss their family history and appropriate screening schedules with their clinician.
The T allele is rare and found almost exclusively in individuals of African ancestry.
High prostate cancer risk
Carrying two copies of the T allele is associated with a substantially higher risk of prostate cancer and a potential for more aggressive disease compared to non-carriers. Research suggests this genotype is significantly enriched in men with a strong family history of prostate cancer; please consult with a healthcare provider regarding personalized screening and monitoring strategies.
This homozygous genotype is rare and limited to populations of African ancestry.
Potential regulatory variant
The G allele is a rare variant observed primarily in populations of European ancestry. While the T allele at this position is a well-documented prostate cancer risk factor in African ancestry populations, the functional implications of the G allele are less characterized in clinical literature.
The G allele is rare, occurring at a frequency of approximately 2% in populations of European ancestry.
What is rs72725854 and where is it located?
The rs72725854 variant is a single nucleotide polymorphism (SNP) situated on chromosome 8q24.21. This region of the human genome is well-known for harboring multiple genetic variants that influence cancer susceptibility. Specifically, rs72725854 is located in an intergenic region, meaning it does not sit within a protein-coding gene. Instead, it resides within a regulatory element known as an enhancer. Enhancers are segments of DNA that act like switches, controlling the activity of nearby genes. Research indicates that this specific enhancer plays a critical role in regulating the expression of several long non-coding RNAs (lncRNAs), such as PCAT1, PRNCR1, and PVT1, as well as the proto-oncogene MYC. By modulating these regulatory hubs, the variant can influence cellular processes that may contribute to disease development.
Research and Prostate Cancer Associations
Scientific studies have identified rs72725854 as a significant genetic risk factor for prostate cancer, particularly in men of African ancestry. Research suggests that the 'T' allele of this variant is associated with a higher risk of developing the disease, as well as an increased likelihood of more aggressive or earlier-onset prostate cancer. The evidence for this association is considered moderate to strong within the context of African ancestry populations. Studies have shown that the risk allele can augment the transcriptional activity of the enhancer, making it more responsive to androgen stimulation. This process leads to the elevated expression of the aforementioned lncRNAs and the MYC oncogene in prostate tumors. Because of these findings, researchers have investigated the variant's role in the familial clustering of prostate cancer, finding it significantly enriched in men with a family history of the disease.
Understanding Your Results
It is important to understand that genetic variants like rs72725854 represent statistical associations rather than diagnostic certainties. Having a specific genotype does not mean an individual will definitely develop prostate cancer, nor does the absence of the variant guarantee protection. This variant is one of many factors—including age, family history, and other genetic and environmental influences—that contribute to overall health outcomes. If you have concerns about your prostate cancer risk or are interested in screening, it is essential to discuss this information with a qualified healthcare provider or a genetic counselor. They can help interpret your results in the context of your personal and family medical history and provide guidance on appropriate screening schedules or clinical management. Never use genetic information to make independent medical decisions or to alter your healthcare plan without professional consultation.
How common is this variant?
The rs72725854 variant is rare and is primarily found in populations of African ancestry, with the risk allele frequency estimated at approximately 6%.
Frequently asked questions
Is rs72725854 found in all populations?
No, research indicates that the risk allele for rs72725854 is specific to populations of African ancestry. It is not typically observed in other ancestral groups.
Does having the T allele mean I will get prostate cancer?
No. Genetic variants indicate a statistical increase in risk, not a diagnosis. Many factors, including lifestyle and other genetic markers, influence your actual risk.
What should I do if I have this variant?
You should discuss your results with your doctor or a genetic counselor. They can evaluate your overall risk profile and determine if specific screening recommendations are appropriate for you.
Is this variant related to other cancers?
While the 8q24 region is linked to various cancers, rs72725854 is most prominently studied and associated with prostate cancer risk in men of African ancestry.
Sources & further reading
Educational information only, last refreshed 10/30/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs72725854?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants
This 3'UTR variant in KCNQ1 modulates gene expression and is linked to clinical variability in QTc intervals.
A 3'UTR variant in KCNQ1 that influences QTc interval duration through allele-specific expression effects.
A 3'UTR variant in KCNQ1 that acts as a regulatory element affecting cardiac repolarization phenotypes.
This variant is significantly associated with the risk of postoperative atrial fibrillation in surgical patient cohorts.
This variant is a downstream modifier of the PITX2 gene and is strongly associated with postoperative atrial fibrillation risk.
A missense variant in PIEZO1 that is specific to South Asian ancestry and associated with alterations in red cell traits and glycated hemoglobin levels.